To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
6 Current news of Medizinische Universität Innsbruckrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Teams of researchers from Charité - Universitätsmedizin Berlin and the Medical University of Innsbruck have developed a new therapeutic concept for the treatment of temporal lobe epilepsy. It represents a gene therapy capable of suppressing seizures at their site of origin on demand. Having been ...
In a project funded by the Austrian Science Fund FWF, Doris Wilflingseder investigates the initial stages of infection - the time span when the immune system might still stop HIV. "HIV has been intensively investigated in research labs all over the world for more than 30 years", says Doris ...
Messenger substance can reduce anxiety
The targeted control of biochemical processes and neuronal signalling pathways using the messenger substance neuropeptide Y could help in the future treatment of anxiety disorders. Palpitations, sweating and sleep problems – most people have already experienced symptoms of anxiety. As a response ...
A protein complex, which is an important link in a cellular transport chain, also initiates the assembly of the next link in the chain. This newly-won insight will now allow a better understanding of a transport process that plays a crucial role in numerous cellular processes including virus ...
A fungus protein that attacks pathogenic fungi is the focal point of a project recently launched by the Austrian Science Fund FWF. As well as examining the structure of the protein, the project will also closely analyse the physiological changes that it causes in the cells of pathogenic fungi. ...
Farfield Scientific has recently been awarded a prestigious contract as part of a pan-European research initiative to develop a diagnostic test for Hepatitis A, B and C. The project, code named SABIO, deploys one of the latest and most sensitive optical sensor technologies based on hollow or ...